|
CCDC7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.44249065417534E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.64233079860787E-13 |
| Normal-vs-Stage2 |
1.382060E-04 |
| Normal-vs-Stage3 |
5.19969999945857E-07 |
| Normal-vs-Stage4 |
2.401700E-04 |
| Stage1-vs-Stage2 |
1.660240E-01 |
| Stage1-vs-Stage3 |
5.044200E-01 |
| Stage1-vs-Stage4 |
1.868060E-02 |
| Stage2-vs-Stage3 |
1.040950E-01 |
| Stage2-vs-Stage4 |
1.987670E-02 |
| Stage3-vs-Stage4 |
1.715820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.67221791969041E-12 |
| Normal-vs-AfricanAmerican |
1.798300E-04 |
| Normal-vs-Asian |
3.363800E-02 |
| Caucasian-vs-AfricanAmerican |
8.781800E-01 |
| Caucasian-vs-Asian |
9.052000E-02 |
| AfricanAmerican-vs-Asian |
1.321770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.19833090304201E-12 |
| Normal-vs-Female |
3.94573262951781E-12 |
| Male-vs-Female |
4.313600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.742100E-02 |
| Normal-vs-Age(41-60Yrs) |
5.38447064712955E-12 |
| Normal-vs-Age(61-80Yrs) |
3.72999964248777E-10 |
| Normal-vs-Age(81-100Yrs) |
2.102700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.475200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.816800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.879960E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.460240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.229200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.529180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.655900E-03 |
| Normal-vs-Grade 2 |
2.53164156305274E-12 |
| Normal-vs-Grade 3 |
6.72849553851051E-11 |
| Normal-vs-Grade 4 |
3.684200E-03 |
| Grade 1-vs-Grade 2 |
6.180600E-01 |
| Grade 1-vs-Grade 3 |
2.289600E-01 |
| Grade 1-vs-Grade 4 |
4.278000E-02 |
| Grade 2-vs-Grade 3 |
1.777600E-01 |
| Grade 2-vs-Grade 4 |
6.336500E-03 |
| Grade 3-vs-Grade 4 |
7.586300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.22044604925031E-16 |
| Normal-vs-ccB subtype |
1.004230E-04 |
| ccA subtype-vs-ccB subtype |
1.63984000000061E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.18699527773947E-11 |
| Normal-vs-N1 |
8.911500E-02 |
| N0-vs-N1 |
3.851400E-01 |
|
|
